APA

Pershina A. G., Demin A. M., Perekucha N. A., Brikunova O. Y., Efimova L. V., Nevskaya K. V., Vakhrushev A. V., Zgoda V. G., Uymin M. A., Minin A. S., Malkeeva D., Kiseleva E., Zima A. P., Krasnov V. P. & Ogorodova L. M.Peptide ligands on the PEGylated nanoparticle surface and human serum composition are key factors for the interaction between immune cells and nanoparticles. : .

Chicago

Pershina A G, Demin A M, Perekucha N A, Brikunova O Ya, Efimova L V, Nevskaya K V, Vakhrushev A V, Zgoda V G, Uymin M A, Minin A S, Malkeeva D, Kiseleva E, Zima A P, Krasnov V P and Ogorodova L M.Peptide ligands on the PEGylated nanoparticle surface and human serum composition are key factors for the interaction between immune cells and nanoparticles. : .

Harvard

Pershina A. G., Demin A. M., Perekucha N. A., Brikunova O. Y., Efimova L. V., Nevskaya K. V., Vakhrushev A. V., Zgoda V. G., Uymin M. A., Minin A. S., Malkeeva D., Kiseleva E., Zima A. P., Krasnov V. P. and Ogorodova L. M.Peptide ligands on the PEGylated nanoparticle surface and human serum composition are key factors for the interaction between immune cells and nanoparticles. : .

MLA

Pershina A G, Demin A M, Perekucha N A, Brikunova O Ya, Efimova L V, Nevskaya K V, Vakhrushev A V, Zgoda V G, Uymin M A, Minin A S, Malkeeva D, Kiseleva E, Zima A P, Krasnov V P and Ogorodova L M.: . .